Athersys (NASDAQ:ATHX) Earns Hold Rating from Analysts at StockNews.com
Investment analysts at StockNews.com began coverage on shares of Athersys (NASDAQ:ATHX – Get Free Report) in a research note issued on Friday. The brokerage set a “hold” rating on the biopharmaceutical company’s stock. Athersys Stock Performance Shares of NASDAQ:ATHX opened at $0.00 on Friday. The stock has a market cap of $61,719.00, a P/E ratio […]
